The multiple The multiple sclerosis community has been waiting with bated breath for the approval of the drug Ocrevus (ocrelizumab), which will be used to treat patients who have relapsing MS and primary progressive MS. The FDA’s decision of final approval arrived on March 28, which coincides with Multiple Sclerosis Awareness Week. In preparation for the announcement, we’ve put together a list […]
The post 5 Things to Know About the New MS Drug Ocrevus appeared first on Multiple Sclerosis News Today.